Imunon, Inc. (IMNN)
0.6049
-0.02
(-3.83%)
USD |
NASDAQ |
Nov 16, 11:33
Imunon Price : 0.6049 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 0.582 | 0.63 | 0.551 | 0.629 | 176044.0 |
| Nov 12, 2026 | 0.76 | 0.815 | 0.495 | 0.6368 | 2.190M |
| Nov 11, 2026 | 0.79 | 0.7968 | 0.6819 | 0.7201 | 128051.0 |
| Nov 10, 2026 | 0.86 | 0.87 | 0.77 | 0.77 | 245855.0 |
| Nov 09, 2026 | 0.85 | 0.9498 | 0.85 | 0.8829 | 72961.00 |
| Nov 06, 2026 | 0.8972 | 0.9255 | 0.8206 | 0.8448 | 89116.00 |
| Nov 05, 2026 | 0.93 | 0.9341 | 0.8651 | 0.9003 | 79008.00 |
| Nov 04, 2026 | 0.97 | 0.9789 | 0.8801 | 0.907 | 22061.00 |
| Nov 03, 2026 | 0.87 | 0.95 | 0.8670 | 0.90 | 61886.00 |
| Nov 02, 2026 | 0.905 | 0.92 | 0.84 | 0.8701 | 72716.00 |
| Oct 30, 2026 | 0.84 | 1.00 | 0.84 | 0.91 | 132515.0 |
| Oct 29, 2026 | 0.859 | 0.8750 | 0.8101 | 0.833 | 211775.0 |
| Oct 28, 2026 | 0.86 | 0.8749 | 0.82 | 0.8301 | 195020.0 |
| Oct 27, 2026 | 0.9525 | 1.01 | 0.83 | 0.8762 | 542685.0 |
| Oct 26, 2026 | 1.25 | 1.27 | 1.185 | 1.23 | 39377.00 |
| Oct 23, 2026 | 1.25 | 1.25 | 1.16 | 1.235 | 22646.00 |
| Oct 22, 2026 | 1.21 | 1.275 | 1.17 | 1.25 | 34861.00 |
| Oct 21, 2026 | 1.03 | 1.209 | 1.01 | 1.19 | 272434.0 |
| Oct 20, 2026 | 0.982 | 1.005 | 0.98 | 1.005 | 44535.00 |
| Oct 19, 2026 | 0.99 | 1.02 | 0.98 | 0.985 | 93795.00 |
| Oct 16, 2026 | 1.05 | 1.05 | 1.01 | 1.02 | 55514.00 |
| Oct 15, 2026 | 1.03 | 1.07 | 1.03 | 1.06 | 39188.00 |
| Oct 14, 2026 | 1.08 | 1.08 | 1.03 | 1.04 | 18974.00 |
| Oct 13, 2026 | 1.07 | 1.08 | 1.007 | 1.07 | 39589.00 |
| Oct 12, 2026 | 1.06 | 1.10 | 1.03 | 1.07 | 42485.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 1.595 |
| Taysha Gene Therapies, Inc. | 4.13 |
| Agenus, Inc. | 6.53 |
| Amgen, Inc. | 469.45 |
| Anika Therapeutics, Inc. | 13.15 |
Price Related Metrics
| Price to Book Value | 1.433 |
| Earnings Yield | -548.7% |
| Market Cap | 2.822M |